G/TBT/N/CAN/534  
 
6 November 2017  
(17-6016) Page: 1/2 
Committee on Technical Barriers to Trade  Original: English/French  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member: CANADA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible: Health Canada  
Name and address (including telephone and fax numbers, email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
Canada 's Notification Authority and Enquiry Point  
Global Affairs Canada  
Technical Barriers and Regulations Division  
111 Sussex Drive  
Ottawa, ON K1A 0G2  
Canada  
Telephone: (343) 203 -4273 
Fax: (613) 943 -0346 
Email: enquirypoint@international.gc.ca   
3. Notified under Article 2.9.2 [  ], 2.10.1 [  ], 5.6.2 [X], 5.7.1 [  ], other:  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable): Drug 
products containing controlled substances (ICS 11.120)  
5. Title, number of pages and language(s) of the notified document: Notice to 
interested parties – Proposed regulations amending regulations under the Controlled Drugs 
and Substances Act with respect to the destruction of controlled substances and 
internation al travel with controlled substances prescrib ed for personal medical use. 
(3 page(s), in English; 3 page(s), in French)   
6. Description of content: This regulatory proposal aims to provide a long -term solution to 
address three problematic areas that are c urrently only addressed using temporary 
measures: the destruction of unserviceable stock containing certain controlled substances 
by pharmacists, practitioners and persons in charge of hospitals; the return of prescription 
drugs containing controlled subst ances by individuals to pharmacies for destruction; and 
individuals entering or leaving Canada with controlled substances for personal medical use.  
This notice provides interested stakeholders with the opportunity to provide comments on 
Health Canada 's int ent to amend the Narcotic Control Regulations (NCR), the  
Benzodiazepines and Other Targeted Substances Regulations (BOTSR) and Part G of the  
Food and Drug Regulations (FDR-G) to address these identified gaps and inconsistencies. 
The publication of this not ice in the Canada Gazette , Part I, initiates a 60 -day comment 
period.   
7. Objective and rationale, including the nature of urgent problems where 
applicable: Protect ion of public health and public safety.  G/TBT/N/CAN/534  
 
- 2 - 
 
  8. Relevant documents:  Canada Gazette , Part I, 28 October 2017, Pages 4128 -4130 
(Available in English and French)   
9. Proposed date of adoption:  Anticipated for Summer 2019  
Proposed date of entry into force:  Upon publication in Canada Gazette, Part II  
10. Final date for comments: 26 December 2017  
11. Texts available from: National enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available, of other body:   
The electronic version of the regulatory text can be downloaded at:  
https://members.wto.org/crnattachments/2017/TBT/CAN/17_4949_00_e.pdf